EU Says J&J Vaccine Benefits Outweigh Risks Despite Clots

The video discusses the similarities between the narratives surrounding the J&J and AstraZeneca vaccines, focusing on the European response to potential side effects. The EMA has reviewed cases in the US and noted that restrictions might be applied to the J&J vaccine, similar to AstraZeneca. This could delay herd immunity projections in Europe and the US, depending on the availability and use of the J&J vaccine.

What are the projected vaccination rates for the European Union if J&J shots are used?

What impact does the absence of J&J shots have on vaccination timelines in the US?